-
Signature
-
/s/ Arthur Reinstein, Attorney-in-Fact
-
Issuer symbol
-
CBOE
-
Transactions as of
-
19 Feb 2025
-
Net transactions value
-
+$9,061
-
Form type
-
4
-
Filing time
-
21 Feb 2025, 16:40:42 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CBOE |
Common Stock |
Options Exercise |
$578,818 |
+2,753 |
+34% |
$210.25 |
10,778 |
19 Feb 2025 |
Direct |
|
| transaction |
CBOE |
Common Stock |
Tax liability |
$265,125 |
-1,261 |
-12% |
$210.25 |
9,517 |
19 Feb 2025 |
Direct |
|
| transaction |
CBOE |
Common Stock |
Options Exercise |
$159,790 |
+760 |
+8% |
$210.25 |
10,277 |
19 Feb 2025 |
Direct |
|
| transaction |
CBOE |
Common Stock |
Tax liability |
$72,116 |
-343 |
-3.3% |
$210.25 |
9,934 |
19 Feb 2025 |
Direct |
|
| transaction |
CBOE |
Common Stock |
Options Exercise |
$770,566 |
+3,665 |
+37% |
$210.25 |
13,599 |
19 Feb 2025 |
Direct |
|
| transaction |
CBOE |
Common Stock |
Tax liability |
$341,446 |
-1,624 |
-12% |
$210.25 |
11,975 |
19 Feb 2025 |
Direct |
|
| transaction |
CBOE |
Common Stock |
Options Exercise |
$645,257 |
+3,069 |
+26% |
$210.25 |
15,044 |
19 Feb 2025 |
Direct |
|
| transaction |
CBOE |
Common Stock |
Tax liability |
$285,940 |
-1,360 |
-9% |
$210.25 |
13,684 |
19 Feb 2025 |
Direct |
|
| transaction |
CBOE |
Common Stock |
Sale |
$77,644 |
-375 |
-2.7% |
$207.05 |
13,309 |
20 Feb 2025 |
Direct |
F1, F2 |
| transaction |
CBOE |
Common Stock |
Sale |
$750,420 |
-3,600 |
-27% |
$208.45 |
9,709 |
20 Feb 2025 |
Direct |
F1, F3 |
| transaction |
CBOE |
Common Stock |
Sale |
$352,680 |
-1,684 |
-17% |
$209.43 |
8,025 |
20 Feb 2025 |
Direct |
F1, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CBOE |
Restricted Stock Units |
Options Exercise |
$0 |
-2,753 |
-100% |
$0.000000 |
0 |
19 Feb 2025 |
Common Stock |
2,753 |
|
Direct |
F5, F6 |
| transaction |
CBOE |
Restricted Stock Units |
Options Exercise |
$0 |
-760 |
-100% |
$0.000000 |
0 |
19 Feb 2025 |
Common Stock |
760 |
|
Direct |
F5, F6 |
| transaction |
CBOE |
Restricted Stock Units |
Options Exercise |
$0 |
-3,665 |
-50% |
$0.000000 |
3,665 |
19 Feb 2025 |
Common Stock |
3,665 |
|
Direct |
F5, F7 |
| transaction |
CBOE |
Restricted Stock Units |
Options Exercise |
$0 |
-3,069 |
-33% |
$0.000000 |
6,138 |
19 Feb 2025 |
Common Stock |
3,069 |
|
Direct |
F5, F8 |
| transaction |
CBOE |
Restricted Stock Units |
Award |
$0 |
+8,175 |
|
$0.000000 |
8,175 |
19 Feb 2025 |
Common Stock |
8,175 |
|
Direct |
F5, F9 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: